Do Hedge Funds Love Orphazyme A/S (ORPH)?
The Insider Monkey team has completed processing the quarterly 13F filings for the March quarter submitted by the hedge funds and other money managers included in our extensive database.
Orphazyme A/S (ORPH)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 0 | $0 | 0% | ||
| 2. | 0 | $0 | 0% | ||
| 3. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
| 4. | Renaissance Technologies Jim Simons | 0 | $0 | 0% |
Institutional Investors' Holdings
News See All
Is Orphazyme (ORPH) A Good Stock To Buy Now?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Fund Resource Center Billionaire Hedge Funds
